Take Your Trading To The Next Level. Get Started Here!

Patients on Alzheimer’s drug Leqembi see benefits over three years, Eisai study says

July 30, 2024 Comments Off

The study results on Leqembi, which Eisai shares with Biogen, also found that Alzheimer’s patients who take the therapy get worse after they stop treatment.